Anaplastic Astrocytoma - 216 Studies Found

Terminated : RO4929097and Bevacizumab in Treating Patients With Progressive or Recurrent Malignant Glioma
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    : 2010-08-25
    :
    • Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097

Active, not recruiting : Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    : 2009-01-15
    :
    • Drug: Bendamustine Hydrochloride

Terminated : Bortezomib in Treating Patients With Recurrent Glioma
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    : 2000-12-06
    : Drug: bortezomib Given IV Other Names:
Completed : Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
: Malignant Brain Tumors
: 1999-11-01
: Drug: Antineoplaston therapy (Atengenal + Astugenal) Adult
Completed : Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
:
  • Anaplastic Astrocytoma
  • Anaplastic Oligoastrocytoma
  • : 2010-11-24
    :
    • Other: Laboratory Biomarker Analysis

Completed : Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
:
  • Glioblastoma Multiforme
  • Fibrillary Astrocytoma of Brain
  • Gl
    : 2013-06-19
    : Drug: SIACI of Erbitux and Bevacizumab Subjects will receive a single intra-arterial dose of Cetuximab (
Completed : Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
:
  • Astrocytoma
  • Oligodendroglioma
  • Oligoastrocytoma
  • : 2013-05-06
Completed : Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligoastrocytoma<
    : 2014-07-15
    :
    • Biological: carboxylesterase-expressing allogeneic neural stem cells

Completed : Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    : 2013-12-13
    :
    • Biological: E. coli CD-expressing genetically modified neural stem cells

Active, not recruiting : Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    : 2012-07-20
    :
    • Biological: Anti-Endoglin Chimeric Monoclonal Antibody TRC105

<<< Previous | Next >>>